An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00818480
First received: January 6, 2009
Last updated: September 26, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)